Look Under The Hood: PBE Has 13% Upside
September 13, 2018 at 07:56 AM EDT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Dynamic Biotechnology & Genome ETF (PBE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $65.42 per unit.